Healthcare Services

One of the Major Drivers of the Gestational Trophoblastic Disease Market Is the The Rise In Infertility Rates Driving The Growth Of The Market Due To Advanced Parental Age And Increased Demand For Fertility Interventions

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Gestational Trophoblastic Disease Market Across 2026–2030?

The gestational trophoblastic disease market has demonstrated consistent expansion in recent years. This market is projected to grow from $2.16 billion in 2025 to $2.26 billion in 2026, reflecting a compound annual growth rate (CAGR) of 4.6%. Historically, this growth can be attributed to several factors including advances in gynecologic oncology, the widespread availability of HCG testing, increased adoption of surgical treatment, heightened awareness regarding rare pregnancy disorders, and established clinical oncology protocols.

The market for gestational trophoblastic disease is anticipated to experience substantial expansion in the coming years. Projections indicate it will reach a valuation of $2.81 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.7%. Key factors contributing to this growth during the forecast period include enhanced diagnostic precision, the proliferation of oncology centers, the establishment of standardized treatment protocols, greater access to healthcare, and a heightened emphasis on managing rare diseases. Significant trends anticipated in the upcoming period encompass refinements in hCG-based disease monitoring, a growing reliance on chemotherapy for GTD management, a stronger emphasis on prompt diagnosis, the expansion of specialized oncology services for women, and enhanced post-treatment follow-up.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13271&type=smp

Which Market Drivers Are Supporting The Expansion Of The Gestational Trophoblastic Disease Market?

The increasing rates of infertility are projected to boost the growth of the gestational trophoblastic disease market in the coming years. Infertility rates describe the proportion of individuals or couples within a population who are unable to conceive naturally after a year of consistent, unprotected sexual activity. The rise in infertility is primarily linked to advanced parental age, as older reproductive ages correlate with diminished egg and sperm quality, reduced fertility, and elevated risks of conception complications. While a pathological condition, gestational trophoblastic disease can offer valuable insights into infertility treatments by illuminating the roles of trophoblastic tissue in implantation and hormone regulation, thereby guiding interventions aimed at improving conception success. For example, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported in April 2023 that approximately 17.5% of the adult population, or about 1 in 6 people worldwide, experience infertility, underscoring the critical need to enhance access to affordable, high-quality fertility care for those affected. Consequently, the escalating infertility rates are propelling the gestational trophoblastic disease market.

Gestational Trophoblastic Disease Market Driver: Impact Of Increasing Cigarette Smoking On The Growth Of The Gestational Trophoblastic Disease Market

What Segmentation Levels Are Considered In The Gestational Trophoblastic Disease Market?

The gestational trophoblastic disease market covered in this report is segmented –

1) By Type: Hydatidiform Mole, Choriocarcinoma, Placental-Site Trophoblastic Tumor, Epithelioid Trophoblastic Tumor, Other Types

2) By Treatment: Surgery, Chemotherapy, Suction Dilation And Curettage (D&C), Radiation Therapy

3) By End User: Hospital And Clinics, Diagnostic Centers, Other End Users

Subsegments:

1) By Hydatidiform Mole: Complete Hydatidiform Mole, Partial Hydatidiform Mole

2) By Choriocarcinoma: Non-Metastatic Choriocarcinoma, Metastatic Choriocarcinoma

3) By Placental-Site Trophoblastic Tumor: PSTT With Normal Placentation, PSTT With Abnormal Placentation

4) By Epithelioid Trophoblastic Tumor: Epithelioid Trophoblastic Tumor With No Evidence Of Metastasis, Epithelioid Trophoblastic Tumor With Metastasis

5) By Other Types: Trophoblastic Tumor Of Unknown Origin, Non-Gestational Trophoblastic Neoplasia

Which Leading Firms Are Contributing To The Growth Of The Gestational Trophoblastic Disease Market?

Major companies operating in the gestational trophoblastic disease market are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Bayer AG, Novartis AG, Merck And Co. Inc., Sun Pharmaceutical Industries Ltd., GSK plc, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd.

Read the full gestational trophoblastic disease market report here:

https://www.thebusinessresearchcompany.com/report/gestational-trophoblastic-disease-global-market-report

How Is The Gestational Trophoblastic Disease Market Distributed Across Key Geographic Regions?

Asia-Pacific was the largest region in the gestational trophoblastic disease market in 2025, and is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational trophoblastic disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gestational Trophoblastic Disease Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13271&type=smp

Browse Through More Reports Similar to the Global Gestational Trophoblastic Disease Market 2026, By The Business Research Company

Type 1 Diabetes Global Market Report

https://www.thebusinessresearchcompany.com/report/type-1-diabetes-global-market-report

Insuman Global Market Report

https://www.thebusinessresearchcompany.com/report/insuman-global-market-report

Diabetes Care Devices Market

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795